Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients

Background: We aimed to investigate molecular factors potentially related to the progression of gastric adenoma (GA) to gastric cancer (GC) and compare the mutation characteristics between GC and GA. Methods: We conducted custom gene panel sequencing for 135 GC-related genes and estimated the differ...

Full description

Bibliographic Details
Main Authors: Seung Woo Lee, Taekyu Lee, Hae Jung Sul, Ki Cheol Park, Joonhong Park
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/9/2038
_version_ 1797534716769861632
author Seung Woo Lee
Taekyu Lee
Hae Jung Sul
Ki Cheol Park
Joonhong Park
author_facet Seung Woo Lee
Taekyu Lee
Hae Jung Sul
Ki Cheol Park
Joonhong Park
author_sort Seung Woo Lee
collection DOAJ
description Background: We aimed to investigate molecular factors potentially related to the progression of gastric adenoma (GA) to gastric cancer (GC) and compare the mutation characteristics between GC and GA. Methods: We conducted custom gene panel sequencing for 135 GC-related genes and estimated the difference in somatic mutation profiles between 20 GC and 20 GA cases. Results: A total of 31 somatic mutations, including 22 missense, 3 nonsense, and 6 frameshift mutations, were detected in 17 samples. We estimated an average of 1.8 mutations per sample (range, 1 to 3 mutations), with 12 in GC and 5 in GA. GC tended to have one or more mutated genes (<i>p</i> = 0.0217), as well as higher allele frequencies of mutated genes (<i>p</i> = 0.0003), compared to GA. Likewise, known driver mutations associated with GC tumorigenesis (<i>TP53</i>, <i>ERBB2</i>, <i>PIK3CA</i>, and <i>RNF43</i>) were identified in half of the GC cases (50%, 10/20; <i>p</i> = 0.0002). Only the mutant burden, regardless of gene type, was retained, with an odds ratio of 1.8392 (95% confidence interval (CI), 1.0071 to 3.3588; <i>p</i> = 0.0474). Conclusion: Our study demonstrates that the accumulation of mutant burden contributes to tumorigenesis progression from GA to GC in Korean patients, regardless of the kind of genes. These findings may elucidate the molecular pathogenesis of gastric carcinogenesis and malignant progression.
first_indexed 2024-03-10T11:34:23Z
format Article
id doaj.art-1f5061db4c714835968a127df49e6dd8
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T11:34:23Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-1f5061db4c714835968a127df49e6dd82023-11-21T18:59:41ZengMDPI AGJournal of Clinical Medicine2077-03832021-05-01109203810.3390/jcm10092038Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma PatientsSeung Woo Lee0Taekyu Lee1Hae Jung Sul2Ki Cheol Park3Joonhong Park4Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaThermo Fisher Scientific Solutions, Seoul 06349, KoreaDepartment of Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaClinical Research Institute, Daejeon St. Mary’s Hospital, The Catholic University of Korea, Daejeon 34943, KoreaDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju 54907, KoreaBackground: We aimed to investigate molecular factors potentially related to the progression of gastric adenoma (GA) to gastric cancer (GC) and compare the mutation characteristics between GC and GA. Methods: We conducted custom gene panel sequencing for 135 GC-related genes and estimated the difference in somatic mutation profiles between 20 GC and 20 GA cases. Results: A total of 31 somatic mutations, including 22 missense, 3 nonsense, and 6 frameshift mutations, were detected in 17 samples. We estimated an average of 1.8 mutations per sample (range, 1 to 3 mutations), with 12 in GC and 5 in GA. GC tended to have one or more mutated genes (<i>p</i> = 0.0217), as well as higher allele frequencies of mutated genes (<i>p</i> = 0.0003), compared to GA. Likewise, known driver mutations associated with GC tumorigenesis (<i>TP53</i>, <i>ERBB2</i>, <i>PIK3CA</i>, and <i>RNF43</i>) were identified in half of the GC cases (50%, 10/20; <i>p</i> = 0.0002). Only the mutant burden, regardless of gene type, was retained, with an odds ratio of 1.8392 (95% confidence interval (CI), 1.0071 to 3.3588; <i>p</i> = 0.0474). Conclusion: Our study demonstrates that the accumulation of mutant burden contributes to tumorigenesis progression from GA to GC in Korean patients, regardless of the kind of genes. These findings may elucidate the molecular pathogenesis of gastric carcinogenesis and malignant progression.https://www.mdpi.com/2077-0383/10/9/2038mutation profilesgastric adenomagastric cancermutant burdennext-generation sequencing
spellingShingle Seung Woo Lee
Taekyu Lee
Hae Jung Sul
Ki Cheol Park
Joonhong Park
Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients
Journal of Clinical Medicine
mutation profiles
gastric adenoma
gastric cancer
mutant burden
next-generation sequencing
title Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients
title_full Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients
title_fullStr Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients
title_full_unstemmed Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients
title_short Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients
title_sort differences in somatic mutation profiles between korean gastric cancer and gastric adenoma patients
topic mutation profiles
gastric adenoma
gastric cancer
mutant burden
next-generation sequencing
url https://www.mdpi.com/2077-0383/10/9/2038
work_keys_str_mv AT seungwoolee differencesinsomaticmutationprofilesbetweenkoreangastriccancerandgastricadenomapatients
AT taekyulee differencesinsomaticmutationprofilesbetweenkoreangastriccancerandgastricadenomapatients
AT haejungsul differencesinsomaticmutationprofilesbetweenkoreangastriccancerandgastricadenomapatients
AT kicheolpark differencesinsomaticmutationprofilesbetweenkoreangastriccancerandgastricadenomapatients
AT joonhongpark differencesinsomaticmutationprofilesbetweenkoreangastriccancerandgastricadenomapatients